On April 25, 2018 this [Drug & Device Law] blog advised “Don’t Sleep on the Dormant Commerce Clause.” It was right. That post discussed a Fourth Circuit case involving a drug pricing regulation attempt by the State of Maryland. Since then, two other Circuit court decisions have followed; it’s the Dormant Commerce Clause gone wild. And both decisions involve subject matter areas of direct interest to readers of this blog.

Read the blog post here.